TG Therapeutics
0 sources
Financials
0001437749-26-006133TG Therapeutics
Summary
TG Therapeutics is a public company[1].
Key Facts
- TG Therapeutics is in the country of United States[2].
- TG Therapeutics is in the country of US[3].
- TG Therapeutics's instance of is recorded as public company[4].
- TG Therapeutics's headquarters location is recorded as New York City[5].
- TG Therapeutics's stock exchange is recorded as Nasdaq[6].
- TG Therapeutics's official website is recorded as http://tgtherapeutics.com[7].
- TG Therapeutics's legal form is recorded as 8888[8].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 529900X21UKABN9NJ529[9]
-
Registered legal name: Tg Therapeutics, Inc.[10]
-
Legal jurisdiction: US-DE[11]
-
GLEIF entity category: GENERAL[12]
-
Legal form (ISO 20275 ELF): 8888[13]
-
Other legal form: Corporation[14]
-
Entity status: ACTIVE[15]
-
LEI registration status: LAPSED[16]
-
LEI first registered: 2018-11-02[17]
-
LEI last updated: 2021-07-19[18]
-
LEI next renewal: 2019-11-02[19]
-
Managing LOU: 5299000J2N45DDNE4Y28[20]
-
Registration authority: RA000602[21]
-
Authority entity ID: 2336756[22]
-
Conformity flag: NON_CONFORMING[23]
Body
Operations
TG Therapeutics's headquarters location is recorded as New York City[5].
Ownership
TG Therapeutics's stock exchange is recorded as Nasdaq[6].